Per Anders Gustav Carlberg

Per Anders Gustav Carlberg discloses dealings in Recipharm AB to Finansinspektionen. We count 4 filings; the first trade dates from 22 February 2019 and the latest from 15 February 2021.

In open-market terms, that means 1 purchase worth €57k on one side and 1 sale worth €1.9M on the other. Netting one side against the other leaves €1.9M of net selling. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. 2021 to date brings no purchases and 1 sale.

On 16 February 2021 came the latest disclosure, an open-market sale for €1.9M in Recipharm AB. The last purchase on record was published on 25 February 2019, which is 2,813 days ago. Between a trade and the moment it shows up on Finansinspektionen, the median delay is 2 days. The regulation allows three business days to notify a trade (MAR article 19). Every figure here comes from the filings published by Finansinspektionen and describes the past, not future prices; it is not investment advice.